Investigation of resistance mechanisms in acute myeloid leukaemia towards tyrosine kinase inhibitors with mass spectrometry
- Weitere Titel
-
Identifizierung von Resistenzmechanismen in der akuten myeloischen Leukämie gegenüber Tyrosinkinase-Hemmern mittels Massenspektrometrie
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
München, Technische Universität München, Dissertation, 2023
- Schlagwort
-
Labormedizin
Molekulare Diagnostik
Leukämie
Lymphom
Akute myeloische Leukämie
Krebs
- Ereignis
-
Veröffentlichung
- (wo)
-
München
- (wer)
-
Universitätsbibliothek der TU München
- (wann)
-
2023
- Urheber
-
Hannane, Nora
- Beteiligte Personen und Organisationen
- URN
-
urn:nbn:de:bvb:91-diss-20231129-1714914-1-1
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
25.03.2025, 13:47 MEZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Hannane, Nora
- Kuhn, Peer-Hendrik
- Götze, Katharina S.
- Universitätsbibliothek der TU München
Entstanden
- 2023
Ähnliche Objekte (12)
Gab2 and its role in Tyrosine Kinase Inhibitor Resistance in chronic myeloid leukemia
Identification of CDX2 targets in acute myeloid leukaemia
Deoxycytidine kinase is downregulated under hypoxic conditions and confers resistance against cytarabine in acute myeloid leukaemia
Axitinib and Sorafenib are potent in tyrosine kinase inhibitor resistant chronic myeloid leukemia cells
Analysis of the impact of Bruton Tyrosine Kinase on Myeloid Cell Development and Function
Editorial: Targeting bruton tyrosine kinase
Infliximab therapy together with tyrosine kinase inhibition targets leukemic stem cells in chronic myeloid leukemia
Loss of heterozygosity in acute myeloid leukaemia with normal karyotype
Metabolic plasticity is an essential requirement of acquired tyrosine kinase inhibitor resistance in chronic myeloid leukemia
NDEL1-PDGFRB fusion gene in a myeloid malignancy with eosinophilia associated with resistance to tyrosine kinase inhibitors
Survivin’ acute Myeloid Leukaemia : a personalised target for inv(16) patients
Sequence analysis of the NUMB gene in chronic myeloid leukaemia patients
Gab2 and its role in Tyrosine Kinase Inhibitor Resistance in chronic myeloid leukemia
Identification of CDX2 targets in acute myeloid leukaemia
Deoxycytidine kinase is downregulated under hypoxic conditions and confers resistance against cytarabine in acute myeloid leukaemia
Axitinib and Sorafenib are potent in tyrosine kinase inhibitor resistant chronic myeloid leukemia cells
Analysis of the impact of Bruton Tyrosine Kinase on Myeloid Cell Development and Function
Editorial: Targeting bruton tyrosine kinase
Infliximab therapy together with tyrosine kinase inhibition targets leukemic stem cells in chronic myeloid leukemia
Loss of heterozygosity in acute myeloid leukaemia with normal karyotype
Metabolic plasticity is an essential requirement of acquired tyrosine kinase inhibitor resistance in chronic myeloid leukemia
NDEL1-PDGFRB fusion gene in a myeloid malignancy with eosinophilia associated with resistance to tyrosine kinase inhibitors
Survivin’ acute Myeloid Leukaemia : a personalised target for inv(16) patients
Sequence analysis of the NUMB gene in chronic myeloid leukaemia patients
Gab2 and its role in Tyrosine Kinase Inhibitor Resistance in chronic myeloid leukemia
Identification of CDX2 targets in acute myeloid leukaemia
Deoxycytidine kinase is downregulated under hypoxic conditions and confers resistance against cytarabine in acute myeloid leukaemia
Axitinib and Sorafenib are potent in tyrosine kinase inhibitor resistant chronic myeloid leukemia cells
Analysis of the impact of Bruton Tyrosine Kinase on Myeloid Cell Development and Function
Editorial: Targeting bruton tyrosine kinase
Infliximab therapy together with tyrosine kinase inhibition targets leukemic stem cells in chronic myeloid leukemia
Loss of heterozygosity in acute myeloid leukaemia with normal karyotype
Metabolic plasticity is an essential requirement of acquired tyrosine kinase inhibitor resistance in chronic myeloid leukemia
NDEL1-PDGFRB fusion gene in a myeloid malignancy with eosinophilia associated with resistance to tyrosine kinase inhibitors
Survivin’ acute Myeloid Leukaemia : a personalised target for inv(16) patients